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Abstract
The key host cellular pathway(s) necessary to control the infection caused by inhalation of the environmental fungal
pathogen Cryptococcus neoformans are still largely unknown. Here we have identified that the sphingolipid pathway in
neutrophils is required for them to exert their killing activity on the fungus. In particular, using both pharmacological and
genetic approaches, we show that inhibition of sphingomyelin synthase (SMS) activity profoundly impairs the killing ability
of neutrophils by preventing the extracellular release of an antifungal factor(s). We next found that inhibition of protein
kinase D (PKD), which controls vesicular sorting and secretion and is regulated by diacylglycerol (DAG) produced by SMS,
totally blocks the extracellular killing activity of neutrophils against C. neoformans. The expression of SMS genes, SMS activity
and the levels of the lipids regulated by SMS (namely sphingomyelin (SM) and DAG) are up-regulated during neutrophil
differentiation. Finally, tissue imaging of lungs infected with C. neoformans using matrix-assisted laser desorption-ionization
mass spectrometry (MALDI-MS), revealed that specific SM species are associated with neutrophil infiltration at the site of the
infection. This study establishes a key role for SMS in the regulation of the killing activity of neutrophils against C.
neoformans through a DAG-PKD dependent mechanism, and provides, for the first time, new insights into the protective
role of host sphingolipids against a fungal infection.
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Introduction
One hundred and sixteen years after the discovery of Cryptococcus
neoformans from fermented peach juice by the Italian Sanfelice [1],
and shortly thereafter from the tibial lesions of a German patient
by Busse [2] and Buschke [3], the total containment of a
cryptococcal infection by the host remains elusive. C. neoformans is
an environmental fungus found worldwide that commonly strikes
those individuals having compromised immune systems [4],
although immunocompetent subjects can also be affected [5].
Infection is initiated upon inhalation of spores or desiccated fungi,
and in the lung C. neoformans proliferates in the alveolar space.
Whereas in immunocompetent subjects the infection is, for the
most part, contained in the lung, in immunocompromised subjects
dissemination of fungal cells from the lung to the brain leads to the
development of a life-threatening meningoencephalitis [6,7,8].
Indeed, deaths by cryptococcosis among HIV-infected patients in
sub-Saharan Africa are more frequent than deaths by tuberculosis
[9].
Almostallreviews onhostdefenseagainst C. neoformansemphasize
the role of cell-mediated immunity (CMI), which is critical for
containment of fungal cells through the activation of macrophages
and neutrophils resulting in granuloma formation [10,11,12].
Although several studies have elucidated the role and mechanisms
by which macrophages, and especially alveolar macrophages,
control C. neoformans infection [6,13,14,15,16,17,18,19,20], very
little is known on the mechanisms by which neutrophils neutralize
C. neoformans. Neutrophils are more effective killers than macro-
phages against fungi [21,22] and they possess the innate ability to
kill microbes without the activation of a cellular mediated immune
response. Very interestingly, transfusion of human neutrophils, as
differentiated HL-60 cells, significantly improves survival of mice
challenged with fungal organisms [23,24], suggesting that these cells
are able to control the infection through their antifungal activity.
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mechanism(s) required for this killing activity is unknown. The
elucidation of these mechanisms regulating their antifungal
properties would not only improve our understanding of the host-
pathogen interaction but it could facilitate the use of such immune
cells in a clinical setting.
In recent years, sphingolipids, and sphingolipid-metabolizing
enzymes, have emerged as key regulators of many physiological
and pathological cellular processes. The study of the role of
sphingolipids in the regulation of infectious diseases is also a
rapidly emerging area of research, but, until very recently, most of
these studies have focused on the role of microbial sphingolipids in
the ability of the microbe to cause infection [25,26]. Very few
studies have addressed whether host sphingolipids are also
involved in the regulation of microbial pathogenesis and nothing
is known about the role of host sphingolipids on fungal infections.
An intriguing sphingolipid metabolizing activity is carried out
by sphingomyelin synthase (SMS), which is encoded by two genes:
SMS1 and SMS2 [27,28,29]. SMS transfers a choline phosphate
moiety from phosphatidylcholine (PC) to ceramide, thereby
producing sphingomyelin (SM) and diacylglycerol (DAG)
[17,29,30]. This class of enzymes is particularly important because
not only does it produce SM, a key component of cellular
membranes, but also because it regulates the level of two bioactive
lipid molecules, such as ceramide and DAG. Since (a) ceramide
can regulate transcription factors, such as NF-kB involved in
cytokine production [31], (b) DAG controls antifungal activity by
neutrophils through reactive oxygen species (ROS) production
[32], and (c) SM has been implicated in controlling the host
immune response in phagocytic cells [33], in this paper we studied
the role of SMS in neutrophils against C. neoformans.
We show herein that inhibition of SMS activity profoundly
impairs the ability of neutrophils to kill C. neoformans cells. We also
provide evidence supporting a mechanism by which SMS
regulates neutrophil killing against C. neoformans through the
production of DAG and the consequent activation of protein
kinase D (PKD).
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Medical University of South
Carolina Institutional Animal Care and Use Committee (Permit
Number: 2019). All animal procedures were performed according
to the approved protocol, and all efforts were made to minimize
suffering.
Materials, strains and growing media
Cryptococcus neoformans variety grubii serotype A strain H99 (WT)
was used in this study, and routinely grown in yeast extract/
peptone/2% dextrose-rich (YPD-rich) medium. HL-60 cells
(ATCCH CCL-240
TM) were cultured at 37uC, 5% CO2 in RPMI
1640, supplemented with L-glutamine, 20% heat-inactivated FBS,
and 1% penicillin and streptomycin. RPMI 1640 medium, FBS
and penicillin-streptomycin were from Gibco/Invitrogen; pooled
human serum, retinoic acid and DMSO were from Sigma. D609
was purchased from Enzo Life Sciences. CID755673 was
purchased from Tocris Bioscience; 1,2-Dioctanoyl-sn-glycerol
(DiC8) was from Cayman Chemical. NBD [N-(7-nitrobenz-2-
oxa-1,3-diazol-4-yl)]-C6-ceramide was purchased from Molecular
Probes. Phosphatidylcholine (PC) was purchased from Avanti
Polar Lipids.
HL-60 killing assay
To quantify the effect of HL-60 cells on C. neoformans (H99), the
killing assay described by Spellberg et al [24] was used with slight
modification. HL-60 cells were differentiated by incubation in the
presence of 1.3% (v/v) DMSO and 2.5 mM retinoic acid up to
72 h in growth medium. Cells were then washed with RPMI
serum free medium and resuspended in fresh RPMI containing
10% pooled human serum. Then, 8610
4 phagocytes were co-
cultured with 4610
3 C. neoformans in a total volume of 1 ml (20:1
ratio HL-60:C. neoformans) for 6 h at 37uC. At the end of the
incubation, the cultures were sonicated using a sonic dismem-
brator Model 500 (Fisher Scientific) at 10% amplitude twice (15
seconds each) on ice, serially diluted and streaked onto YPD agar,
and incubated for 48 h at 30uC. CFUs were counted to assess
killing of C. neoformans compared with control cultures of C.
neoformans alone with no HL-60 cells.
SMS inhibition assay
To test whether SMS activity is required for activated HL-60
cells to kill C. neoformans, the pharmacological SMS inhibitor D609
was used. Following incubation with 1.3% (v/v) DMSO and
2.5 mM retinoic acid for 72 h, cells were washed, and 8610
4
phagocytes in 1 ml were resuspended in fresh RPMI and 10%
pooled human serum and incubated with D609 (50 mg/ml) for
2 h. Then, 4610
3 C. neoformans cells were added (20:1 ratio HL-
60:C. neoformans) for an additional 4 h. At the end of the
incubation, the cultures were sonicated, serially diluted and
streaked onto YPD agar, and incubated for 48 h at 30uC. CFUs
were counted to assess killing of C. neoformans compared with
control cultures of C. neoformans alone with no HL-60 cells.
SMS activity assay
HL-60 cells (undifferentiated and differentiated for 72 h) were
collected and the pellet rinsed with PBS then resuspended in
100 ml of ice-cold lysis buffer. For the experiments in which D609
(50 mg/ml) was used, the inhibitor was incubated with HL-60 cells
for 6 h post-differentiation, at 37uC prior to cell collection. The
lysis buffer consisted of 25 mM Tris/HCl (pH 7.4), 5 mM EDTA,
1% phosphatase inhibitor and 1% protease inhibitor (both from
Thermo Scientific). Cell lysates were sonicated using a sonic
dismembrator Model 500 (Fisher Scientific) at 10% amplitude
twice (15 seconds each) on ice, then centrifuged at 400 g for 5
minutes at 4uC. The supernatant was used for measuring
enzymatic activity. Protein concentrations were determined using
the Bio-Rad assay. The SMS assay was performed using 150 mgo f
protein. The substrate was prepared as a mixture of 40 mM NBD-
C6 ceramide and 200 mM phosphatidylcholine (PC) resuspended
in 100 mM Tris/HCl (pH 7.4), 50 mM KCl and 1 mM EDTA by
sonication (ultrasonic water bath) and vortexing in turn until clear.
The substrate was diluted 1:1 with the proteins resuspended in lysis
buffer (final incubation volume of 200 ml), and the incubation was
carried out for 30 min at 30uC. The reaction was stopped on ice
by addition of 3 vol. of chloroform/methanol (1:1 v/v). After
vortexing, the phases were clarified by centrifugation at 2400 g for
5 min. The lower phase was transferred to new tubes, dried down,
and the lipids resuspended with 40 ml of chloroform/methanol (2:1
v/v) and separated by TLC in chloroform:/methanol/15 mM
CaCl2 (90:52.5:12 by vol.). Fluorescence was measured using a
Storm 860 Imaging Analysis System from Amersham Biosciences
(U.K.). Results were analyzed using ImageQuant software from
Amersham Biosciences.
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Down-regulation of SMS1 and SMS2 was achieved with siRNA
oligonucleotides targeting SMS1: ACAGCTTACCTAGATCA-
TAAA (SMS1.2 siRNA) and CACACTATGGCCAATCAGCAA
(SMS1.4 siRNA), or SMS2: AAGGCACCAAAAAGTACCCGG
(SMS2.0 siRNA), andACCGTCATGATCACAGTTGTA(SMS2.3
siRNA) synthesized by Qiagen, and by using Nucleofector Solution
V nucleofection reagent (Lonza). The non-specific All Star siRNA
sequence (SCR; scrambled siRNA) was used as control (Qiagen).
Typically, 2610
6 HL-60 cells from an exponentially growing culture
not exceeding 25 passages were nucleofected with 4.5 mgs i R N A
according to the manufacturer’s directions with the following
modification. After 30 minutes of incubation at 37uC, 5% CO2 in
500 ml of growth medium, cells were seeded at 1610
5 cells/ml. Cells
were then treated with 1.3% (v/v) DMSO and 2.5 mM retinoic acid.
After 48 h, cells were collected and frozen at 280uCf o rR T - P C R .
For the killing assay, cells were spun at 800 g for 5 minutes at RT.
Pellets were resuspended with RPMI containing 10% human serum.
Eight610
4differentiated cells wereincubated with C. neoformans for an
additional 4 h in a ratio of 20:1 HL-60:C. neoformans in a total volume
of 1 ml. At the end of the incubation, the cultures were serially diluted
and streaked onto YPD agar, and incubated for 48 h at 30uC. CFUs
were counted to assess killing of C. neoformans compared with control
cultures of C. neoformans alone with no HL-60 cells.
Real-time RT-PCR
Total RNA was extracted using an RNeasy Mini Kit (Qiagen)
following the manufacturer’s suggested protocol (including the
optional DNase and wash steps). Real time PCR was performed as
indicated by Villani et al [30]. The results were normalized to an
internal control gene, glyceraldehyde-3 phosphate dehydrogenase
(GAPDH). The real-time RT–PCR results were analysed using Q-
GeneH software, which expresses data as the means of normalized
expression. The primers were designed using PerkinElmer Primer
ExpressH software. Primer sequences were as follows: GAPDH,
forward: 59-CACCAGGGCTGCTTTTAACTCTGGTA-39, re-
verse: 59-CCTTGACGGTGCCATGGAATTTGC-39; SMS1,
forward: 59-GCCAGGACTTGATCAACCTAACC-39, reverse:
59-CCATTGGCATGGCCGTTCTTG-39; SMS2, forward: 59-
TC-ACCCAGTGGCTGTTTCTGA-39, reverse: 59-TGCATT-
CCAGGCACAGGTAGA-39.
Flow cytometry analysis
HL-60 cells (1610
5 cells/ml, total 20 ml) were treated with
1.3% (v/v) DMSO and 2.5 mM retinoic acid. At the indicated time
points cells were collected and analyzed for the CD11b surface
marker which is constitutively expressed in neutrophils by flow
cytometry using a BD FACSCalibur
TM platform with fluorescein
isothiocyanate (FITC) labeled antibodies (AbD Serotec) according
to the manufacturer’s recommended dilution and protocol. Briefly,
1610
6 cells (in 100 ml) were incubated with the 500 ng of antibody
in PBS containing 2% FBS for 20 minutes on ice, washed with
PBS supplemented with 2% FBS, and re-suspended with 500 mlo f
PBS supplemented with 2% FBS and analyzed by flow cytometry.
The concentration of the antibodies was optimized using positive
controls, and negative isotype controls were employed to exclude
non-specific binding. For experiments using siRNA, differentiation
was initiated immediately after the siRNA transfection and
allowed to proceed for 48 hours.
HL-60 medium killing assay
Undifferentiated and differentiated HL-60 cells were washed
with RPMI serum free medium and re-suspended in fresh RPMI
supplemented with 10% pooled human serum. Next, 8610
4 HL-
60 cells were incubated in 1 ml for 6 hours in the presence or
absence of inhibitors (D609 or PKD1 inhibitor CID755673).
Conditioned media (900 ml) were then collected by centrifugation
and 4610
3 C. neoformans cells/ml added and allowed to incubate
for 4 h at 37uC. At the end of the incubation, the medium was
serially diluted and streaked onto YPD agar, and incubated for
48 h at 30uC. CFUs were counted to assess killing of C. neoformans
in the absence or presence of inhibitors compared with control
cultures of C. neoformans alone in fresh medium.
Down-regulation of PKD1 and PKD2
Down-regulation of PKD1 and PKD2 was achieved with siRNA
oligonucleotides targeting PKD1 (59GUCGAGAGAAGAGGU-
CAAATT39), or PKD2 (59GCAAAGACUGCAAGUUUAATT39,
PKD2.1; 59GGACAUCAAUGACCAGAUCTT-39, PKD2.2) syn-
thesized by Qiagen. The non-specific All Star siRNA sequence
(SCR; scrambled siRNA) was used as control (Qiagen). Down-
regulation of PKD1 and PKD2 was achieved by nucleofecting cells
with 4.5 mg siRNA as described for SMS. Cells were then treated
with 1.3% (v/v) DMSO and 2.5 mM retinoic acid. After 48 h, cells
were collected and frozen at 280uC for Western blotting, or used
immediately for incubation with C. neoformans in the killing assay as
previously described for SMS down-regulation.
Western Blot of PKD
HL-60 cells (1610
5 cells/ml, total 40 ml) were treated with
1.3% (v/v) DMSO and 2.5 mM retinoic acid. At the indicated time
points (24, 48 and 72 hrs), 6610
6 cells were collected and PKD1,
PKD2 and PKD3 protein expression was assayed by Western
blotting. For experiments with siRNA, cells were nucleofected with
SCR, PKD1, PKD2.1 and PKD2.2 siRNA as described for SMS.
After 48 hours of differentiation cells were collected and processed
for western blotting. Three million cells were harvested on ice,
washed in PBS and resuspended in 80 ml of doubly distilled water
containing Pierce Halt protease inhibitor and 5 mM PMSF. Cells
were then lysed by sonication using a sonic dismembrator
(conditions described above; optimization experiment showed
100% cell lysis with these conditions). Protein concentration was
determined using the Bio-Rad protein determination assay
reagent. Fifty mg of total proteins for PKD1 and 10 mg of total
proteins for PKD2 and PKD3 were separated by 10% SDS-PAGE
under reducing conditions and transferred to nitrocellulose
membranes. Membranes were blocked with 2% BSA containing
PBS-Tween 0.1% for 1 hour at room temperature. Membranes
were then incubated with PKD1, PKD2, PKD3 antibodies
(1:1000 dilution) (PKD1 from Cell Signaling Technology, PKD2
& PKD3 from Bethyl Laboratories) overnight with continuous
shaking at 4uC. After extensive washings, membranes were next
incubated with peroxidase-conjugated donkey-anti-rabbit
(1:10,000, Santa Cruz Biotechnology Inc.) in 2% BSA PBS-
Tween 0.1% for 1 hour at room temperature. Signals were
visualized using SuperSignal West Femto (Thermo Scientific) and
exposure to Kodak BioMax MR Film. GAPDH was used as a
loading control. The intensity of the signal was determined by
densitometry using Labworks Image Acquisition and Analysis
software from UVP BioImaging Systems, version 4.5.
HL-60 killing assay in the presence of DiC8
To test whether exposure of HL-60 cells to the DAG analogue
1,2-Dioctanoyl-sn-glycerol (DiC8) improves the killing effect
observed by differentiated HL-60 cells, following incubation with
1.3% (v/v) DMSO and 2.5 mM retinoic acid as described above,
8610
4 cells were washed, re-suspended in 1 ml fresh RPMI
Role of SMS against Cryptococcal Infection
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concentrations of DiC8 for 2 h. Then, 4610
3 C. neoformans cells
were added (20:1 ratio HL-60:C. neoformans) for an additional 4 h.
At the end of the incubation, the cultures were serially diluted and
streaked onto YPD agar, and incubated for 48 h at 30uC. CFUs
were counted to assess killing of C. neoformans compared with
control cultures of C. neoformans alone with no HL-60 cells.
SM, ceramide and DAG determination
Undifferentiated and differentiated HL-60 cells (1610
6) were
washed with PBS, and frozen pellets were submitted for mass
spectral data acquisition at the Medical University of South
Carolina Lipidomics Facility. For lipid analysis in lung tissues,
lungs from 2 mice from each time point were homogenized in 5 ml
homogenization buffer consisting of 0.25 M sucrose, 0.5 mM
EDTA, 25 mM KCl, and 50 mM TRIS-HCl at pH 7.4. Then,
1 mg of homogenate was used for the mass spectrometry analysis
whereas an aliquot was used for the quantitation of GAPDH by
Western blot using the LabWorks Image Acquisition and Analysis
software from UVP BioImaging Systems, version 4.5. Lipids were
extracted and analyzed using established protocols in the facility
[34,35].
Animal studies
Four- to six-week old CBA/J mice from Jackson Laboratories
were used for this study. Mice were anesthesized by intraperitoneal
injection of 60 ml of a xylazine-ketamine mixture containing 5 mg
xylazine and 95 mg ketamine per kg of body weight. The wild-
type strain (H99) of C. neoformans was grown in YPD medium for
24 h at 30uC. The fungal cells were harvested, washed three times
in PBS, and resuspended in PBS at a concentration of
2.5610
7 cells/ml. Mice were infected intranasally with 20 ml
containing 5610
5 cells. Mice were fed ad libitum and monitored by
inspection twice a day. Mice that appeared moribund or in pain
were sacrificed using CO2 inhalation followed by cervical
dislocation. All animal procedures were approved by the Medical
University of South Carolina Institutional Animal Care and Use
Committee and followed the guidelines of the American
Veterinary Medical Association.
Tissue sectioning and sample preparation
At 6, 12 and 18 days post infection, mice were euthanized and
lungs were harvested and flash-frozen in dry-ice/ethanol, then
stored at -80uC until ready for use. The organ was attached to the
cryostat sample stage using a small bead of optimal cutting
temperature compound (OCT) at the base of the tissue only. The
tissue was sectioned to a thickness of 20 mm at a temperature of
226uC using a cryotome (Microm HM 550, Walldorf, Germany).
The sections were thaw-mounted onto conductive indium tin
oxide (ITO) coated conductive glass slides for mass spectral
analysis (Bruker Daltonics, Billerica, MA), or superfrosted glass
slides for mucicarmine and hematoxylin and eosin staining. The
resistance of the ITO coated microscope slide was 40 V over a
distance of 1 cm. The tissue was allowed to warm on the
microscope slides for 10 s before refreezing and storage at 280uC.
For mass spectrometric analysis, the tissue sections were removed
from the freezer and placed in a dessicator for 30 min prior to
matrix deposition. A freshly prepared solution of 2,5-dihydrox-
ybenzoic acid (DHB) (Sigma), (40 mg/ml in 70% ethanol), was
applied to the tissue by repeated cycles using a TLC sprayer. Each
spray cycle was followed by 45–60 s of drying time, and the cycle
repeated until an even coverage of matrix across the entire tissue
was achieved.
MALDI Mass Spectrometry SM Imaging
MALDI mass spectral analysis was carried out using a reflector
time-of-flight mass spectrometer (Bruker Autoflex III TOF-TOF,
Bruker Daltonik, Bremen, Germany) operating in positive ion
mode with a +20 kV accelerating potential. The laser beam size
was set to medium, and operated at 200 Hz. Using Bruker Peptide
Standard 1 (Bruker Daltonik, Bremen, Germany), a linear,
external calibration was applied to the instrument before data
collection. Mass spectral data sets were acquired over each whole
mouse lung using flexImaging
TM software (Bruker Daltonik,
Bremen, Germany) in the mass range of m/z 500–1200 with a
raster step size of 100 mm and 250 laser shots per spectrum. After
data acquisition, molecular images were reconstituted using
flexImaging
TM software. Each data set consists of approximately
4,000 individual sampling locations, each representing one pixel in
the resultant image. Data was normalized using flexImaging
TM
software, and each m/z signal plotted 60.5 mass units. For display
purposes, signals between sampling locations were interpolated
and pixel intensities were scaled to utilize the entire dynamic
range. Tandem mass spectrometry was used to identify signals
detected in the MALDI imaging data sets. Lipids to be identified
were extracted from mouse lung tissue by homogenization of the
tissue in 70% ethanol. Samples were centrifuged at 45,000 rpm for
30 minutes at 4uC using a Beckman Optima TL Ultracentrifuge
with a TLA45 rotor (Beckman Coulter, Inc., Fullerton, CA), and
the supernatant containing extracted lipids removed. Samples
were concentrated using a speed-vac (Labconco, Kansas City,
MO), and spotted on a MALDI plate using 40 mg/ml DHB in
70% ethanol. Standard solutions of known lipids were also spotted
in a similar manner. A timed ion gate was used for precursor ion
selection and the fragments generated were further accelerated
with 19 kV in the LIFT cell, and detected following passage
through the reflectron. No CID gas was used for fragmentation of
the precursor ions. Signals in the MALDI tissue imaging data set
were identified based on matching fragmentation spectra of lipids
extracted from the tissue and prepared lipid standard solutions.
Neutrophil killing assay
Approximately 6.4610
4 fresh human normal peripheral blood-
neutrophils per ml (AllCells) were incubated in 124 ml sterile
filtered PBS supplemented with 10% pooled human serum for
2 hours in the absence or presence of inhibitors (SMS inhibitor
D609 or PKD1 inhibitor CID755673). Then, 10 mlo f4 610
4 C.
neoformans cells/ml were added (20:1 ratio neutrophils:C. neoformans)
for an additional 4 h. At the end of the incubation, the cultures
were sonicated, serially diluted and streaked onto YPD agar, and
incubated for 48 h at 30uC. CFUs were counted to assess killing of
C. neoformans compared with control cultures of C. neoformans alone
with no neutrophils. Murine neutrophils were obtained from
CBA/J mice by Ficoll-Hypaque separation according to the
procedure of Culpitt [36]. Mouse sera was obtained from CBA/J
mice. The killing assay for murine neutrophils was identical to that
described for human neutrophils.
Statistics
All experiments were performed at least in triplicate. Statistical
analysis of the data were performed using Student’s t-test, and
P,0.05 was considered statistically significant.
Results
Differentiated HL-60 cells kill C. neoformans
To study how neutrophils control C. neoformans, we used an in
vitro human cell system that was characterized a few years ago in
Role of SMS against Cryptococcal Infection
PLoS ONE | www.plosone.org 4 December 2010 | Volume 5 | Issue 12 | e15587an elegant study by Spellberg and co-workers [24]. Therefore, to
determine the anticryptococcal activity of neutrophils, 8610
4 HL-
60 phagocytes (differentiated or undifferentiated) were co-cultured
with 4610
3 C. neoformans wild-type H99 (20:1 ratio) as described in
the Materials and Methods Section. Fungal cells were serially
passaged twice in yeast extract/peptone/dextrose (YPD) broth and
washed twice with phosphate buffered saline (PBS) prior to the co-
incubation. Following co-incubation, the culture was sonicated,
serially diluted and plated onto YPD agar and incubated at 30uC
for 48 hours to determine colony forming unit (CFU) counts in
order to assess C. neoformans viability. Sonication conditions were
optimized to achieve lysis of mammalian cells and 100% viability
of fungal cells (data not shown). Results are expressed as the
percent reduction of CFU from fungal-phagocyte co-cultures versus
simultaneous culture of C. neoformans without phagocytes. Exper-
iments were performed in triplicate and repeated three times.
Since C. neoformans alone in this minimum medium does not
replicate during the period of incubation, a reduction of C.
neoformans cell number in the presence of differentiated HL-60
indicate killing of C. neoformans (percentage killing). A ,4 fold
increase of killing activity against C. neoformans was observed when
HL-60 were differentiated (32%) as compared to undifferentiated
(7%) (Figure 1A). These results suggest that, in addition to Candida
albicans (Ca), differentiated HL-60 can also efficiently kill C.
neoformans. Interestingly, the killing activity of differentiated HL-60
against Ca increased by only ,2 fold compared to the one
observed with undifferentiated cells [24]. This suggests that the
killing activity of differentiated HL-60 towards C. neoformans seems
to be more pronounced than the one observed against Ca.
Inhibition of SMS activity totally abrogated the killing
activity by HL-60 differentiated cells
Since SM, ceramide and DAG are important lipids involved in
controlling the host immune responses [31,37,38,39,40,41,42], we
investigated whether SMS activity is required for neutrophils to kill
C. neoformans. To address this question, SMS activity was inhibited
with the pharmacological SMS inhibitor D609 [34,43,44] and C.
neoformans survival examined in treated versus untreated cells. After
72 hours of differentiation, 8610
4 phagocytes were incubated with
50 mg/ml of D609 for 2 hours (dose and time adequate to inhibit
SMS activity in various cell lines) [44,45]. Next, 4610
3 C.
neoformans wild-type H99 cells were added for an additional
4 hours at 37uC in RPMI +10% pooled human serum. During this
time, D609 was still present in the medium in order to maintain
SMS activity as low as possible even in the presence of C. neoformans
cells. As control, the effect of D609 (50 mg/ml) was determined on
viability of either C. neoformans cells alone (CFU after 4 hours
incubation) or HL-60 cells in the absence of C. neoformans (trypan
blue exclusion after 6 hours of incubation). In both cases, no
cytotoxic effect was induced by D609 (Figure 1A). As shown in
Figure 1A, D609 totally inhibited the killing activity of
differentiated HL-60 cells, suggesting that differentiated HL-60
cells kill C. neoformans through an SMS-mediated mechanism.
SMS activity increases in differentiated compared to
undifferentiated HL-60 cells
To study whether SMS could be involved in the killing activity
of HL-60, it was examined whether differentiation of HL-60
would increase SMS activity. Following differentiation of HL-60,
proteins were extracted and assayed for SMS activity using well-
established and published methods [30]. SMS activity was found
to be up-regulated in differentiated compared to undifferentiated
HL-60 and incubation with the SMS inhibitor D609 inhibited
SMS activity of differentiated HL-60 cells (Figure 1B).
Down-regulation of either SMS1 or SMS2 decreases
killing of C. neoformans by differentiated HL-60 cells
In mammalian cells SMS activity is encoded by two genes:
SMS1 and SMS2 [27], and in differentiated HL-60 cells both genes
are expressed (Figure S1). Interestingly and in agreement with
the increase of total SMS activity observed in differentiated HL-60
cells (Figure 1B), both SMS1 and SMS2 expression increased in
the course of the differentiation process (Figure S1). In order to
Figure 1. (A). Killing activity of HL-60 cells against C. neoformans (Cn) increases with differentiation and it is abrogated by inhibition of
sphingomyelin synthase activity. Percentage killing of C. neoformans wild-type H99 by HL-60 cells undifferentiated (UD) and differentiated (D) with
retinoic acid and DMSO. *, P,0.05. Treatment with sphingomyelin synthase inhibitor D609 completely abolished the killing activity of differentiated
(D) cells. D609 has no effect on Cn cells. (B) Differentiation of HL-60 cells increases SMS activity. Sphingomyelin synthase (SMS) activity increases in
HL-60 differentiated (D) compared to undifferentiated (UD) cells. Treatment with SMS inhibitor D609 decreases SMS activity of HL-60 D. Results show
are from 3 independent experiments.
doi:10.1371/journal.pone.0015587.g001
Role of SMS against Cryptococcal Infection
PLoS ONE | www.plosone.org 5 December 2010 | Volume 5 | Issue 12 | e15587study the role of these genes in the antifungal activity of
differentiated HL-60, short interfering RNA (siRNA) was used.
The siRNA treatment was optimized so that, after down-
regulation, SMSs expression in differentiated cells would approx-
imate the levels found in undifferentiated cells. Cells were treated
with siRNA against SMS1 (SMS 1.2 and SMS 1.4), SMS2 (SMS2.0
and SMS 2.3) or scrambled control (SCR) together with the agents
required to induce differentiation towards the granulocytic lineage.
The LonzaH NucleofectorH optimized protocol for HL-60 cells
was used to transfer the siRNA into the cells. After optimization
experiments, it was found that transfection of 4.5 mg of siRNA for
48 hours was the optimal concentration to down-regulate gene
levels to those found in undifferentiated cells (Figure 2A and B).
Importantly, no significant changes in SMS2 levels were observed
when SMS1 was down-regulated (Figure 2A) and vice versa
(Figure 2B) indicating the absence of cross-target effects.
Thus, to test the effect of down-regulation of SMS1 or SMS2 on
the extracellular killing of C. neoformans by differentiated HL-60,
SMS down-regulated cells (48 h of siRNA transfection and
differentiation) were incubated with C. neoformans for 4 h in a
20:1 ratio (HL-60:C. neoformans), as previously described. The
cultures were then collected, processed and plated for fungal
CFUs. As a control for fungal growth, C. neoformans was incubated
in the absence of HL-60 cells. The killing activity is represented by
the percentage of C. neoformans CFU recovered from C. neoformans
incubated alone minus the C. neoformans CFU recovered from C.
neoformans cells incubated with differentiated HL-60 from each
experimental group, divided by C. neoformans CFU recovered from
C. neoformans incubated alone (Figure 2C). It was found that both
SMS1 (SMS1.3 and 1.4) and SMS2 (SMS2.0 and 2.3) siRNA
significantly inhibited the killing of C. neoformans cells. These results
provide further evidence that differentiated HL-60 cells kill C.
neoformans by an SMS-mediated mechanism.
SMS knockdown by siRNA does not affect HL-60 cell
differentiation
In order to demonstrate that knockdown of SMS1 and SMS2 by
siRNA did not affect differentiation, expression of the neutrophil
cell-surface marker CD11b was determined. First, expression of
CD11b was confirmed during the neutrophilic differentiation of
HL-60 cells (Figure 3A). Indeed, expression of CD11b reached a
maximum after 48 h and this maximum was sustained at 72 h.
Therefore, following transfection of SCR, SMS1 or SMS2 siRNA,
the cells were tested for CD11b expression after 48 hours of
Figure 2. Effect of modulation of either SMS1 or SMS2 during differentiation of HL-60 cells. Two million HL-60 cells were transfected with
4.5 mg of SCR, SMS1 siRNA (1.2 and 1.4), and SMS2 siRNA (2.0, 2.3) by nucleofection. Differentiation and down-regulation were induced for 48 hours.
(A and B) Total RNA was extracted, and RT-PCR was performed using specific primers for SMS1 or SMS2 and GAPDH. The RT-PCR results were analyzed
using Q-gene software which expresses data as the means of normalized expression (Fold response relative to SCR-UD). SMS1 mRNA expression was
down-regulated by both SMS1.2 and SMS1.4 siRNA (A) and SMS2 mRNA expression was down-regulated by both SMS2.0 and SMS 2.3 siRNA (B). Data
are the results of at least 3 independent experiments; error bars represent SD and * P,0.05 compared to SCR siRNA undifferentiated cells; # P,0.05
compared with SCR siRNA differentiated cells. (C) Inhibition of either SMS1 or SMS2 mRNA by siRNA blocks the killing activity of differentiated HL-60
cells; results are representative of at least 3 independent experiments. UD: undifferentiated cells; D: differentiated cells; SCR: scrambled control siRNA.
MNE: mean of normalized expression. * P,0.05 compared with SCR siRNA differentiated cells.
doi:10.1371/journal.pone.0015587.g002
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by itself had the tendency to elevate CD11b expression, albeit not
significantly. Nevertheless, a significant increase of CD11b
expression was observed after differentiation of scrambled siRNA
treated cells (UD SCR siRNA versus D SCR siRNA). Most
importantly, expression of the CD11b marker upon differentiation
was not affected by SMS1 or SMS2 siRNA. These results suggest
that the observed increase in SMS activity during differentiation
(Figure 1B) is rather a consequence and not an inducer of
neutrophilic differentiation of HL-60 cells and that the effect
observed after down-regulation of SMS1 or SMS2 on the killing
activity of HL-60 cells (Figure 2C) was not due to an impairment
of the differentiation process.
The killing activity of differentiated HL-60 is due to
antifungal factors present in the medium
To decipher the mechanism by which differentiated HL-60 cells
kill C. neoformans, it was examined whether these phagocytes would
internalize C. neoformans during the time of incubation and, thus,
kill them intracellularly through the phagolysosome, or whether
the differentiation process would promote the release of some host
factor(s) in the medium that would kill C. neoformans extracellularly.
To address whether phagocytosis would occur, 8610
4 differenti-
ated HL-60 cells were incubated with 4610
3 C. neoformans cells, as
described above for the killing experiment. At different time points
(1, 2, 3 and 4 hours of co-incubation) the phagocytic index was
determined by microscopic observation. At all time points, not a
single C. neoformans cell was observed within HL-60 cells
(differentiated or undifferentiated) (data not shown). This is most
likely due to the unfavorable ratio of C. neoformans versus HL-60
cells (1:20) used in the assay. These results suggest that the killing
activity of HL-60 under these in vitro conditions is not mediated by
phagocytosis and intracellular killing of C. neoformans.
Therefore, to test whether the release of antimicrobial factors by
HL-60 cells is responsible for the killing of C. neoformans,8 610
4
HL-60 cells were differentiated, washed, incubated in fresh
medium for 6 hours. The medium was then collected by
centrifugation and combined with 4610
3 C. neoformans cells as
above. As a control for killing, C. neoformans cells were incubated
with the medium collected from undifferentiated cells. As a control
for CFU, C. neoformans cells were incubated with fresh medium.
CFU of C. neoformans in conditioned media (from differentiated or
undifferentiated HL-60) were normalized with CFU of C.
neoformans in fresh medium. It was found that conditioned media
collected from differentiated HL-60 significantly killed C. neofor-
mans cells (Figure 4A) in a similar pattern as observed when C.
neoformans cells were incubated in the presence of HL-60 cells
(compare Figure 4A with Figure 1A). Very interestingly, media
collected from differentiated cells treated with D609 is no longer
capable of killing C. neoformans (Figure 4A). These results strongly
suggest that the killing activity of differentiated HL-60 might be
Figure 3. Analysis of CD11b differentiation marker by flow cytometry. (A) HL-60 cells were plated at 1610
5 cells/mL and differentiation
induced. Undifferentiated cells received vehicle solution for the retinoic acid. Differentiated and undifferentiated cells were collected at the indicated
time points and processed for flow cytometric analysis of CD11b positive cells. * P,0.05 compared with undifferentiated time-matched samples. (B)
Effect of modulation of either SMS1 or SMS2 on differentiation of HL-60 cells by analysis of CD11b differentiation marker using flow cytometry. Two
million HL-60 cells were transfected with 4.5 mg of SCR siRNA, SMS1 siRNA (1.2 and 1.4), and SMS2 siRNA (2.0, 2.3) by nucleofection. Downregulation
and differentiation proceeded for 48 hours. Cells were then collected and processed for flow cytometric analysis of CD11b. * P,0.05 compared with
SCR siRNA undifferentiated cells. UD: undifferentiated cells; D: differentiated cells; CT MOCK: control for transfection reagent; SCR: control scrambled
siRNA.
doi:10.1371/journal.pone.0015587.g003
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secretion may be controlled by SMS.
Inhibition of Protein Kinase D (PKD) decreases the killing
activity of differentiated HL-60
It has been shown that diacylglycerol (DAG) produced by SMS1
or SMS2 regulates the localization of PKD at the Golgi [30], and
that the PKD at the Golgi, in turn, regulates vesicular trafficking
and secretion. Thus we investigated the involvement of PKD in
the extracellular killing activity of differentiated HL-60 cells. To
this aim, we employed a specific PKD1 inhibitor, benzoxoloaze-
pinolone (CID755673) that was recently identified and character-
ized [46]. Similarly to the experimental design in which SMS
inhibitor was used (Figure 4A), different concentrations of the
PKD1 inhibitor were incubated with differentiated HL-60, and
after 6 hours of incubation the medium was collected and added
to C. neoformans cells. It was found that treatment with 1 mMo f
CID755673 completely blocked the killing activity of the
conditioned medium of differentiated HL-60 cells (Figure 4B).
This inhibition was also observed when 5 and 10 mM CID755673
were used. As a control, CID755673 was tested for a possible effect
on C. neoformans growth and HL-60 viability, and it was found that
CFU of C. neoformans plus CID755673 were not different from
CFU of C. neoformans minus CID755673 (Figure 4B). Also,
CID755673 had no effect on HL-60 viability analyzed by Trypan
blue exclusion (data not shown). These results suggest that PKD1
regulates the killing of C. neoformans by neutrophils through the
secretion of an anti-cryptococcal factor(s) in the medium.
Down-regulation of PKD1 but not PKD2 decreases killing
of C. neoformans by differentiated HL-60 cells
Since the pharmacological inhibitor CID755673 inhibited
killing of C. neoformans, we wanted to confirm this observation by
specific down-regulation of PKD isoforms. Western Blotting
(Figure 5A) analysis revealed that of the three PKD isoforms
only PKD1 and PKD2 are expressed over the time course of
differentiation whereas PKD3 protein levels remain unchanged.
Therefore we sought to specifically down-regulate PKD1 and
PKD2 in differentiated HL-60 cells to the levels observed in
undifferentiated cells. To control for the efficacy and specificity of
siRNA down-regulation, protein expression was analyzed by
western blotting. As shown in Figure 5B, down-regulation of
PKD1 did not affect PKD2 expression (Figure 5B, left panel
and Supplementary Figure S4), and only the PKD2.2 siRNA
sequence was effective in reducing PKD2 expression (Figure 5B,
right panel) without reducing PKD1 levels. Therefore, to test the
effect of specific down-regulation of PKD1 or PKD2 on the
extracellular killing of C. neoformans by differentiated HL-60, down-
regulated cells were incubated with C. neoformans for 4 h in a 20:1
ratio (HL-60:C. neoformans), as described previously. The cultures
were then collected and plated for fungal CFUs (Figure 5C). As a
control for fungal growth, C. neoformans was incubated in the
absence of HL-60 cells. The killing activity is represented by the
percentage of C. neoformans CFU recovered from C. neoformans
incubated alone minus the C. neoformans CFU recovered from C.
neoformans cells incubated with differentiated HL-60 from each
experimental group, divided by C. neoformans CFU recovered from
C. neoformans incubated alone. It was found that only down-
regulation of PKD1 and not PKD2 inhibited the killing of C.
neoformans cells. These results provide further evidence that
inhibition of PKD1 decreases the killing activity of differentiated
HL-60 cells and that the specific isoform involved in regulating
secretion of antifungal factor(s) must be PKD1. As observed with
down-regulation of SMSs, down-regulation of PKDs did not
impair differentiation of HL-60 cells (Figure S2).
Diacylglycerol increases in differentiated compared to
undifferentiated neutrophils
Since DAG produced by SMS1 or SMS2 regulates the
localization of PKD at the Golgi [30], and SMS activity
significantly increases in differentiated versus undifferentiated cells
(Figure 1B), it was next examined by mass spectrometry whether
DAG levels, as a result of SMS activity, would change in
differentiated compared to undifferentiated cells. Total DAG
levels increased in differentiated versus undifferentiated HL-60 cells
(Figure 6A). In particular, it was found that DAG 18:0/20:4 was
Figure 4. Effect of conditioned media on the killing activity of HL-60 cells. (A) Percentage killing of C. neoformans wild-type H99 (Cn)b y
conditioned media collected from HL-60 cells undifferentiated (UD), differentiated (D), from HL60 D treated with D609 or by D609 itself. (B) Effect of
PKD inhibitor on the killing activity of differentiated HL-60 cells against C. neoformans (Cn) or against C. neoformans alone. Percentage killing of Cn
wild-type H99 by conditioned media collected from HL-60 cells undifferentiated (UD), differentiated (D) and from HL60 D treated with the PKD1
inhibitor benzoxoloazepinolone (CID755673). # P,0.05 compared with UD cells. * P,0.05, compared to untreated D cells.
doi:10.1371/journal.pone.0015587.g004
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the granulocytic lineage (Figure 6B). We also found that two
other DAG species (18:0/18:1 and Di C18:0) followed the same
pattern observed for DAG 18:0/20:4 (data not shown). Other
DAG species did not change significantly during differentiation
(data not shown). These results suggest that, in differentiated HL-
60 cells, the DAG profile supports the observed increase in SMS
activity. We next examined the effect of exposure of differentiated
HL-60 cells to exogenous DAG to see if killing effects were
improved. To this aim, we employed 1,2-dioctanoyl-sn-glycerol
(DiC8), a cell permeable analog of DAG. Similar to the
experimental design in which SMS inhibitor was used
(Figure 1A) different concentrations of DiC8 were incubated
with differentiated HL-60, and after 2 hours of incubation C.
neoformans cells were added. We found that treatment with 10 mM
of DiC8 (dose adequate to mimic DAG-mediated effects in
different cell lines; [30] improves the killing activity 11-fold
compared to undifferentiated cells versus ,2.5-fold for differenti-
ated cells alone (Figure 6C). This effect is also observed when
25 mM is used. When used at less than 10 mM, DiC8 had no effect
in differentiated HL-60 cells. As a control, DiC8 was tested for a
possible effect on C. neoformans growth and HL-60 viability, and it
was found that CFU of C. neoformans plus DiC8 were not different
from CFU of C. neoformans minus DiC8 (Figure 6C). Also, DiC8
had no effect on HL-60 viability analyzed by Trypan blue
exclusion (data not shown). These results support the involvement
of DAG in the killing activity of HL-60 cells.
Sphingomyelin increases in differentiated compared to
undifferentiated neutrophils
Since sphingomyelin (SM) is also one of the lipids regulated by
SMS, it was next examined by mass spectrometry whether SM
levels, as a read out of SMS activity, would also change in
differentiated versus undifferentiated cells. It was found that the
total level of SM increased in differentiated compared to
undifferentiated HL-60 cells (Figure 7A) and that this increase
Figure 5. PKD isoforms during HL-60 cell differentiation. (A) HL-60 cells were plated at 1610
5 cells/ml and differentiation was induced.
Differentiated and undifferentiated cells were collected at 24, 48 and 72 hrs and cellular lysates analyzed by Western blot for PKD1, PKD2, PKD3 and
GAPDH. Blots are representative of 3 experiments. (B) Effect of modulation of either PKD1 or PKD2 by siRNA on PKD1 and PKD2 protein levels and
GAPDH as loading control. (C) Effect of PKDs siRNA on the killing activity of differentiated HL-60 cells against C. neoformans. Results are representative
of at least 3 independent experiments. * P,0.05, compared to D-SCR cells. UD, undifferentiated cells; D, differentiated cells; SCR: control scrambled
siRNA.
doi:10.1371/journal.pone.0015587.g005
Role of SMS against Cryptococcal Infection
PLoS ONE | www.plosone.org 9 December 2010 | Volume 5 | Issue 12 | e15587was due in particular to SM species 16:0 (characterized by the
presence of palmitic acid attached to the sphingosine backbone)
(Figure 7B). SM 16:0 is the most abundant SM species in HL-60
cells, followed by SM 24:1 [47] (which contains nervonic acid
attached to the sphingosine backbone). SM 24:1, as well as other
minor SM species, did not significantly change between the HL-60
undifferentiated and differentiated phenotype (data not shown).
On the other hand, the total level of ceramide, substrate of the
SMS reaction, did not change significantly (Figure S3A) nor any
of the species including ceramide C16:0 (Figure S3B). Overall,
the observed lipid changes, in particular SM and DAG, support
the enhanced SMS activity found in differentiated HL-60 cells.
MALDI lung imaging during C. neoformans infection
revealed a differential distribution of sphingomyelin (SM)
species
Since fungal and mammalian cells produce similar species of
DAG and ceramide, changes in these lipids cannot be used to
study the role of SMS during C. neoformans infection. However,
since SM is not produced by C. neoformans, its level in infected tissue
will directly represent the level of activation of SMS (also only
present in mammals and not in fungi). Since SM is the most
abundant sphingolipid in membranes of mammalian cells, its high
level allows a qualitative and quantitative assessment of SMS
activity both in host cells and in tissues. Thus, to study whether
SMS activity in the lung environment changes upon C. neoformans
infection, measurements of SM were used as read out. To this aim,
matrix-assisted laser desorption/ionization-mass spectrometric
imaging (MALDI-MSI) was used. MALDI-MSI allows the
visualization of the spatial distribution of specific molecules,
according to their m/z ratio, within thin sections of tissue. The
identification of the imaged molecule (e.g. lipid) was accomplished
by MALDI tandem mass spectrometry where fragmentation
patterns were compared to those of SM standards (see experi-
mental procedures).
Since SM 16:0 was particularly elevated in the in vitro studies
and this SM species is the most abundant in mammalian cells, we
focused on the MALDI analysis of lung tissues of SM 16:0.
Remarkably, there is a dramatic difference in the distribution of
SM 16:0 species in C. neoformans-infected versus uninfected lung
(Figure 8). Whereas the signal associated with SM 16:0 is low
and homogenously distributed in the uninfected lung, in lungs
from infected mice it appears increased, clustered and more
concentrated in specific areas and totally absent in other areas,
especially at day 18 of infection. When the same lung was stained
with hematoxylin and eosin (H&E), it was found that the areas in
which SM is highly concentrated are also heavily infiltrated with
neutrophils (Figure 8). This suggests that the different distribution
Figure 6. Mass spectrometry analysis of diacylglycerol in HL-60. (A) Total levels of DAG in HL-60 undifferentiated (UD), differentiated (D) and
HL-60 D treated with D609, as measured by LC-MS and normalized by nanomole of lipid inorganic phosphate (Pi); * P,0.05, compared to UD cells. (B)
Specific lipid species for DAG (18:0/20:4) in HL-60 undifferentiated (UD), differentiated (D) and HL-60 D treated with D609, as measured by LC-MS and
normalized by Pi. * P,0.05, compared to UD cells. (C) Effect of DiC8 addition on killing activity of differentiated HL-60 cells against C. neoformans (Cn)
or C. neoformans alone, represented as a fold response relative to HL-60 undifferentiated cells (UD). * P,0.05, compared to untreated D cells.
doi:10.1371/journal.pone.0015587.g006
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neutrophils at the site of the infection and perhaps to an increased
production of this lipid by phagocytes.
The second most abundant SM species in mammalian cells is
SM 24:1. Thus, SM 24:1 was also analyzed by MALDI imaging.
In contrast to SM 16:0, SM 24:1 is distributed in a totally different
manner (Figure 9). The signal associated with SM 24:1 is almost
absent in lung tissues (infected or uninfected) and exclusively
present in lymph nodes, in which lymphocytic cells predominate,
as illustrated by the H&E staining (Figure 9). These results
suggest that SM species are differentially represented in lung
tissues. These results also suggest that different host immune cells
may produce different species of SM; phagocytic cells seem to be
specialized in producing SM 16:0 whereas lymphocytes may be
specialized in producing SM 24:1.
Lipid analysis by HPLC-MS/MS
While MALDI tissue imaging provides a sense of local
expression levels, it does not provide a quantitative assessment of
the total molecule(s) in the tissue. Therefore liquid chromatogra-
phy-mass spectrometry (LC-MS) was performed in total lung
homogenates and the level of different species of SM was
measured. Before proceeding with the determination of the
sphingolipid measurements in infected lungs, several pilot
experiments were performed in uninfected mice to determine
the best way to normalize the results. In fact, since SM is only
present in mammalian cells, it was important to identify a factor
that would be only expressed in mammalian cells and whose
expression does not change during the course of the infection. This
factor could be then used to normalize tissue SM level in both
uninfected and infected lungs. Two mammalian proteins were
considered for investigation: b-actin and glyceraldehyde 3-
phosphate dehydrogenase (GAPDH). b-actin was excluded
because anti-b-actin antibody (GenScript) cross-reacted against
C. neoformans actin (data not shown). The antibody anti-GAPDH
(Ambion) reacted against mammalian GAPDH only and did not
cross-react with C. neoformans GAPDH or any other protein
extracted from a C. neoformans cell culture (inset in Figure 10).
Thus, a mammalian recombinant GAPDH obtained from Sigma
was used to produce a standard curve, which then was used to
determine the amount of GAPDH in uninfected and infected
lungs at day 6, 12 and 18 days post infection (data not shown). It
was found that the level of mouse GAPDH in lungs did not
significantly change upon the challenge with C. neoformans (data not
shown), indicating that this mammalian protein could successfully
be used to normalize the lipid data.
Therefore, a different set of uninfected and infected lungs were
separately homogenized, and an aliquot of the homogenate was
used for the mass spectral data acquisition and another aliquot was
used for the quantitation of GAPDH by Western blot using the
LabWorks Image Acquisition and Analysis software from UVP
BioImaging Systems, version 4.5. The results in Figure 10
illustrate the detection of different species of SM, such as 16:0,
18:0, 18:1, 20:0, 20:1, 22:0, 22:1, 24:0, and 24:1. Among the
measured species, SM 16:0 and 24:1 were the most abundant.
This was not surprising because these two species have been shown
to be the most abundant in many cellular types and tissues
[47,48,49,50,51,52,53]. Importantly, LC-MS results showed that
only SM 16:0 is significantly elevated at day 18 post infection
compared to uninfected mice, suggesting an increased represen-
tation of this sphingolipid in the lung during the C. neoformans
infection. We could not detect any SM 14:0, 26:0 and 26:1,
suggesting that these species are either not produced by cells found
in the mouse lung or that their levels are too low to be detected by
MS. These data corroborate the results observed using MALDI
imaging and point to phagocytic cells as the main producers of SM
in lung infected by C. neoformans.
Neutrophils kill C. neoformans cells and inhibition of both
SMS activity and PKD totally abrogates the killing activity
by neutrophils
In order to investigate the physiological relevance of our
observations, we sought to investigate if neutrophils would be
activated on exposure to C. neoformans cells and kill them. To this
Figure 7. Mass spectrometry analysis of sphingomyelin in HL-60. (A) Total levels of SM in HL-60 undifferentiated (UD), differentiated (D) and
HL-60 D treated with D609, as measured by LC-MS and normalized by nanomole of lipid inorganic phosphate (Pi). * P,0.05, compared to UD cells. (B)
Specific lipid species for SM (16:0) in HL-60 undifferentiated (UD), differentiated (D) and HL-60 D treated with D609, as measured by LC-MS and
normalized by Pi. * P,0.05, compared to UD cells.
doi:10.1371/journal.pone.0015587.g007
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neutrophils and murine neutrophils and carried out the killing
assay as described previously (Figure 1A). It was found that both
human and mouse neutrophils kill C. neoformans and that the
pharmacological SMS inhibitor protected C. neoformans from the
killing activity of human and mouse neutrophils approximately 2-
fold and 3-fold respectively (Figure 11A). Similarly, 0.2 mM of the
PKD1 inhibitor CID755673 [reported IC50 for CID755673 [46]]
protected the survival of C. neoformans during incubation with
human neutrophils by a factor of almost 3 (Figure 11B). The
difference in the effective CID755673 concentration between
primary and cultured neutrophils (Figure 4B) may be attributable
to relative levels and activities of endogenous PKDs [46].
Discussion
In this investigation, the role of host sphingolipids during an
infection caused by the fungal pathogen C. neoformans has been
studied. Our results show that neutrophilic cells kill C. neoformans in
an SMS-dependent manner. Furthermore, the killing activity of
these cells is mainly due to secreted molecule(s) found in the
medium and its release is dependent on PKD1 activity.
To investigate the relationship between SMS and its effect on
killing of C. neoformans by differentiated HL-60 cells, we utilized two
approaches: pharmacological and siRNA inhibition. D609, a
pharmacological PC-PLC inhibitor, has previously been shown to
inhibit SMS activity in vitro [27,44,54], and cellular studies showed
that SMS activity was inhibited by concentrations used to
previously study PC-PLC [43,44,55]. Those results showed that
while it is thought that D609 may be non-specific, SMS is an
important biochemical target for D609. The possibility that many
of the roles of PC-PLC may be attributable to SMS cannot be
ruled out, particularly as the PC-PLC gene has not been identified
in mammalian cells [56]. In order to rule out any off-target effects
of the inhibitor however, we also utilized a siRNA approach.
The use of siRNA to SMS1 and SMS2 allowed us to show that
both SMSs play a role in the extracellular killing of C. neoformans by
neutrophils. Interestingly, the depletion of either SMS1 or SMS2 by
siRNA strongly inhibits the antimicrobial action of HL-60. One
might have expected a partial effect but a total blockage may
suggest that SMS activity at the Golgi upon siRNA reaches a low
‘‘threshold’’ level after which the antimicrobial activity of these
cells is totally lost. The involvement of both SMSs in this process is
not surprising as we propose that the SMS activity responsible for
C. neoformans killing is the one present at the Golgi. Previous studies
have shown that down-regulation of SMS1 or SMS2 reduces de-novo
synthesis of SM each by 30–70% depending on the cell type
Figure 8. Matrix-assisted laser desorption-ionization mass spectrometry (MALDI-MS) of SM C16:0 in lung infected with C.
neoformans. Lungs of CBA/J uninfected and infected mice with C. neoformans wild-type H99 strain were processed for MALDI tissue imaging and
bright field photograph (2X) of a lung section stained with mucicarmine. Sphingomyelin (SM) 16:0 species ([M+Na]
+ m/z 725) is concentrated in areas
highly infiltrated with neutrophils, especially at 18 days of infection, as showed by hematoxylin and eosin staining at right. Min and Max, minimum
and maximum intensity, respectively. N, neutrophils in dotted circle; black bar, 20 mm.
doi:10.1371/journal.pone.0015587.g008
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these observations indicate that SMS1 and SMS2 show compa-
rable activities in this organelle. As a consequence, the killing
activity regulated by the SMS1-DAG-PKD1 pathway is compa-
rable to the one regulated by SMS2-DAG-PKD1. On the other
hand, SMS2 is also present at the plasma membrane [27,30] but
our results suggest that this pool may not be relevant to the
antimicrobial action of neutrophils against C. neoformans. To our
knowledge, this is the first evidence showing that SMS is directly
involved in the regulation of the killing of a fungal organism by
cultured and fresh neutrophils.
It is interesting to note that the killing activity of the medium is
lower than the killing activity of the cells (compare Figures 1A
and 4A). The medium used in Figure 4A was obtained after
6 hours incubation of differentiated HL-60 cells in fresh medium,
to reproduce the conditions used for the killing of C. neoformans by
HL-60 cells illustrated in Figure 1A. Thus, the presence of any
antifungal factor(s) in the medium (Figure 4A) is the result of
constitutive secretion by differentiated cells that have not been
exposed to C. neoformans cells. This secretion is clearly blocked by
SMS and PKD1 inhibitors, suggesting a role for SMS-PKD1
pathway in this process. Interestingly, the killing activity of the
differentiated cells (Figure 1A) is higher than that of the medium
alone. Since in our experimental conditions, we have not observed
intracellular killing of C. neoformans by differentiated HL-60, it is
reasonable to hypothesize that the presence of C. neoformans cells
may enhance the secretion of antifungal factors. In addition, since
inhibition of SMS activity (either with D609 or siRNA) during the
co-incubation of C. neoformans with differentiated HL-60 cells
completely blocks the extracellular killing, it is proposed that SMS
not only has a role in constitutive but also in the C. neoformans-
induced secretion of antifungal factors.
In previous studies, we showed that DAG produced in the Golgi
by SMS favors PKD1 translocation to this organelle [30] where it
initiates trans Golgi network (TGN)-mediated secretion [57,58]
and we also observed that SMS1 and SMS2 modulate protein
trafficking from the TGN to the plasma membrane and secretion
(Marimuthu, Qureshi and Luberto, submitted). In the present
study, we provide evidence of the involvement of SMS and
specifically of PKD1 in the secretion of antimicrobial factors. In
fact, treatment with benzoxoloazepinolone (CID755673), which at
the concentrations used in this study specifically targets PKD1
Figure 9. Matrix-assisted laser desorption-ionization mass spectrometry (MALDI-MS) of SM C24:1 in lung infected with C.
neoformans. Lungs of CBA/J uninfected and infected mice with C. neoformans wild-type strain were assayed for MALDI tissue imaging and bright
field photograph (2X) of a lung section stained with mucicarmine. Sphingomyelin (SM) 24:1 ([M+Na]
+ m/z 835) species is not concentrated in the lung
but in hilar and apical lymph nodes, as showed by hematoxylin and eosin staining. (Ln, lymph node). Min and Max, minimum and maximum intensity,
respectively. L, lymphocytes in dotted circle. White bar, 20 mm.
doi:10.1371/journal.pone.0015587.g009
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from differentiated HL-60 cells (Figure 4B), and from fresh human
neutrophils (Figure 11B). In addition siRNA targeting PKD1, but
not that targeting PKD2, inhibited the killing of C. neoformans
(Figure 5C), supporting an isoform-specific function. So far, three
PKD isoforms (PKD1, PKD2 and PKD3) have been described
[59,60], thus we also investigated the role of PKD3, in our system.
Differently from PKD1 or PKD2, PKD3 level did not increase
during differentiation, suggesting that its activity is not regulated
during differentiation as PKD1 or PKD2. On the other hand, a role
for PKD3 in secretion of antimicrobial factors cannot be ruled out.
Although all PKDs are regulated by a DAG-binding C1 domain
and by an activation loop, they have been shown to regulate
secretion of different cargo molecules. For instance, PKD1 has been
involved in secretion of matrix metalloproteinase-2 and -9 from
prostate cancer cells [61] or of insulin [62]; PKD2 was shown to
regulate hypoxia-induced VEGF-A secretion from pancreatic
tumor cells [63] or secretion of chromogranin A from neuroendo-
crine tumor cells [64]; and PKD3 promoted secretion of
cholecystokinin-mediated pancreatic amylase [65]. On the other
hand, none of the PKDs has ever been linked to the release of
antimicrobial peptides and/or regulation of infections, thus our
studies are novel. Moreover, the fact that exposure of neutrophilic
cells to C. neoformans may stimulate secretion and that this stimulated
secretion is under the control of SMS activity suggests involvement
of PKD1 activity not only in constitutive but also in regulated
secretion, an area of investigation not thoroughly developed yet.
Since PKD1 is activated by DAG, the observed increase of
DAG during differentiation of HL-60 cells (Figure 6A and 6B)i n
the background of elevated SMS activity (Figure 1B), supports
the mechanism whereby SMS regulates PKD1 through the
production of DAG. This is further supported by the fact that
the exogenously added DAG analogue, DiC8 also improved the
killing of C. neoformans. Interestingly, ceramide level does not
change upon differentiation (Figure S3). This may suggest a
compensatory mechanism by other sphingolipid metabolizing
enzymes involved in the production of this sphingolipid [66].
Whereas DAG seems to be the bioactive mediator of SMS
activity in this model, SM can be employed as a read-out for
changes in SMS activity since SM significantly increases during
differentiation (Figure 7A, 7B), in agreement with the observed
increase in SMS activity (Figure 1B). In line with these
observations, MALDI-MSI results clearly show that primary
neutrophils are loaded with SM C16:0 similarly to the cell culture
model (differentiated HL-60), and thus SM captured by this
technique can be considered as a spatial read out for SMS activity
in tissue section. These results are even more significant because,
in contrast to DAG, SM is the only mammalian specific
component of the SMS reaction and it is not present in C.
neoformans cells. Thus, host SM level and distribution can be
unequivocally determined in tissues infected with C. neoformans.
Interestingly, phagocytic cells seem specialized to produce SM
16:0, whereas lymphocytes may produce SM 24:1. Using classical
histology analysis, we observed that the areas in which SM 16:0 is
highly concentrated are heavily infiltrated with neutrophils, which
increase over the duration of infection. This distribution of SM 16:0
over time may be due either to the relocation of resident lung
neutrophils at the site of infection and/or recruitment of additional
phagocytes to the site. Since LC-MSanalysis of SM species reveals a
net increase of SM 16:0 in the lungs in the course of the infection, it
is possible that along with the re-distribution of phagocytes there
might be also a stimulation of SM synthesis. On the other hand, it is
Figure 10. Liquid Chromatography Mass spectrometry (LC/MS) analysis of mouse lungs infected with wild-type C neoformans (Cn).
Quantitative measurements by mass spectrometry (HPLC-MS/MS) of different sphingomyelin (SM) species in uninfected and Wild-type (WT)-infected
lungs excised from CBA/J mice. Data were normalized to the level of mouse GAPDH protein in lungs using mammalian anti -glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) antibody from Ambion (Cat # AM4300), which shows specificity against the mammalian and not against the Cn
GAPDH protein (inset). *, P,0.05, Day 18 versus Day 12.
doi:10.1371/journal.pone.0015587.g010
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the recruitment of phagocytes from the bloodstream to the lung. To
our knowledge, this is the first time that the MALDI-MS imaging
technology has been used to examine how host sphingolipids are
modulated during an infection.
We cannot rule out that the increase of SM at the site of
infection may contribute to the antifungal activity by phagocytic
cells in vivo. In fact, it has been shown that SM itself can enhance
NFkB activation [33], and NFkB is a transcription factor and a
well-known regulator of a variety of host immune cellular
responses against infection [39]. In addition, receptor-mediated
NFkB activation, and its target gene expression, is impaired in
sms2-/- knockout mice [38], suggesting that the regulation of the
antifungal action by SMS may involve the regulation of gene
transcription in addition to protein secretion. DAG can also
activate NFkB [33,45] and thus, DAG and SM can act
synergistically in promoting the killing activity of fungi by
neutrophils. These possibilities may have an impact during the
infection in the animal where interaction between different
immune cells is important to control C. neoformans. On the other
hand, it is not a likely scenario in the in vitro system, in which the
differentiated HL-60 cells are the only player against C. neoformans.
Given the antifungal activity of SMS in neutrophils, an up-
regulation of SMS activity (e.g. by lentiviral expression) in these
cells may enhance their killing activity towards microorganisms
that cause infection. This strategy could be employed to replenish
the killing activity of these cells, especially in conditions of
immunodeficiency in which the antimicrobial activity of resident
neutrophils could be impaired.
Studies on host defense against C. neoformans emphasize the
critical role of T cell immunity for containment of C. neoformans
infection through the activation of macrophages and the
recruitment of neutrophils resulting in granuloma formation in
healthy individuals (Reviewed in [10,11,12]). Although macro-
phages are considered the first line of defense against C. neoformans,
the role of neutrophils is equally important because, once
recruited, they are extremely efficient in killing C. neoformans and
other fungal cells [21,22]. Indeed, macrophages are known to kill
microorganisms mainly by phagocytosis whereas neutrophils,
beside phagocytosis, also kill extracellularly, as extensively
discussed in a recent review by Silva [67]. On the other hand,
previous studies in mice have shown that neutropenia via antibody
depletion resulted in no effect on C. neoformans virulence in i.v.
infection whereas with i.n. infection neutropenic mice actually
survived longer [68]. These results could simply be related to the
inability of mouse neutrophils to produce a-defensin [69]. Thus,
studies in transgenic mice in which neutrophils are expression
human a-defensin are warranted to understand the precise
contribution of these immune cells to the host fight against C.
neoformans and, eventually, to identify the molecular modulator(s) of
their immune activity. This is important because the possibility to
use modified human neutrophils as a mean to combat fungal
Figure 11. Effect of inhibitors on C. neoformans killing in the presence of neutrophils. (A) Effect of SMS inhibition on C. neoformans killing
in the presence of neutrophils: 50 mg/ml D609 inhibits killing of C. neoformans in human and mouse neutrophils. *, P,0.05, treated versus human
untreated cells; #, P,0.05, treated versus mouse untreated cells. (B) Effect of PKD1 inhibition (CID 755673) on killing of C. neoformans in the presence
and in absence (-N) of human neutrophils. *, P,0.05, treated versus untreated cells.
doi:10.1371/journal.pone.0015587.g011
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exploited also against C. neoformans.
The identity of the antimicrobial factors present in the medium
and responsible for the killing of C. neoformans cells by neutrophils is
currently unknown. Neutrophils produce numerous antimicrobial
granules and enzymes over the course of differentiation and release
them extracellularly [21,22] [71]. Among these antimicrobial factors,
defensins and myeloperoxidase (MPO) seem to be the primary
candidates in our experimental model. In fact, defensins have been
shown to be extremely cytotoxic towards C. neoformans [72,73] and
mice lacking MPO are hyper-susceptible to C. neoformans [74,75] and
other fungal infections [74,76,77]. Thus, in future experimentation, it
is our intension to identify the antifungal factors under the control of
the SMS-PKD1 pathway starting with these candidates.
In conclusion, these studies indicate a key role for SMS in the
regulation of the killing activity of neutrophils against C. neoformans
and this killing activity appears to be regulated by the lipid, in
particular DAG, produced by SMS. We also propose that the
mechanism by which SMS mediates the killing by neutrophils is
through modulation of extracellular release of antifungal factor(s)
through a PKD1-mediated mechanism. These studies reveal a
novel role for the host sphingolipid pathway in the regulation of
the infection caused by C. neoformans, and provide new insights into
the mechanisms by which host sphingolipids control infections.
These mechanisms could be exploited for the development of
novel therapeutic strategies.
Supporting Information
Figure S1 Changes in the mRNA levels of SMS isoforms during
HL-60 cell differentiation induced by DMSO and retinoic acid. HL-
60 cells were plated at 1610
5 cells/ml and differentiation induced by
treating with 1.3% DMSO and 2.5 mM retinoic acid. Undifferenti-
ated cells received only vehicle solution for retinoic acid. Differenti-
ated and undifferentiated cells were collected at 24, 48 and 72 hrs,
total RNA was extracted, and RT-PCR was performed using specific
primers for SMS1 (A)o rSMS2 (B)a n dGAPDH. The RT-PCR results
were analysed using Q-gene software, which expresses data as the
means of normalized expression. Results are representative of at least
3 independent experiments, and error bars represent SD and
*P,0.05 compared with respective undifferentiated cells.
(TIF)
Figure S2 Effect of modulation of either PKD 1 or PKD 2 on
HL-60 cell differentiation. Two million HL-60 cells were
transfected with 4.5 mg of SCR, PKD1 siRNA, PKD2 (PKD2.2)
siRNA by nucleofection. Differentiation was induced with DMSO
and RA. Cells were collected at 48 hours and processed for flow
cytometry analysis of CD11b positive cells. Results are represen-
tative of at least 3 independent experiments, and error bars
represent SD and *P,0.05 compared with SCR undifferentiated
cells. UD, undifferentiated; D, differentiated cells.
(TIF)
Figure S3 Mass spectrometry analysis of ceramide in HL-60. (A)
Total levels of ceramide, in HL-60 undifferentiated (UD),
differentiated (D) and HL-60 D treated with D609, as measured
by LC-MS and normalized by nanomole of lipid inorganic
phosphate (Pi). (B) Specific lipid species for ceramide (16:0) in HL-
60 undifferentiated (UD), differentiated (D) and HL-60 D treated
with D609, as measured by LC-MS and normalized by Pi.
*P,0.05 compared UD cells.
(TIF)
Figure S4 Quantitative analysis of Western blot of Pkd1 in
Figure 5B. Intensity of the bands were calculated using LabWork
Software. AU, arbitrary units.
(TIF)
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